Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
European Archives of Psychiatry and Clinical Neuroscience|November 19, 2004
Clinical effects of COX-2 inhibitors on cognition in schizophreniaNorbert Müller, Michael Riedel, Markus J Schwarz, et al.The American Journal of Psychiatry|February 2, 2002
Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trialsStefan Leucht, Gabi Pitschel-Walz, Rolf R Engel, et al.Schizophrenia Bulletin|August 15, 2006
Is the superior efficacy of new generation antipsychotics an artifact of LOCF?Stefan Leucht, Rolf R Engel, Josef Bäuml, et al.The Cochrane Database of Systematic Reviews|July 10, 2014
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophreniaMagdolna Tardy, Maximilian Huhn, Werner Kissling, et al.Journal of Affective Disorders|October 15, 2017
Translating the HAM-D into the MADRS and vice versa with equipercentile linkingStefan Leucht, Hein Fennema, Rolf R Engel, et al.Paediatric and Perinatal Epidemiology|August 2, 2006
Influence of prior assignment on refusal rates in a trial of supplemental oxygen for retinopathy of prematurityRolf R Engel, Neal L Oden, Geoff R Cohen, et al.The Journal of Clinical Psychiatry|June 27, 2007
Psychoeducation in schizophrenia: 7-year follow-up concerning rehospitalization and days in hospital in the Munich Psychosis Information Project StudyJoseph Bäuml, Gabriele Pitschel-Walz, Anja Volz, et al.European Archives of Psychiatry and Clinical Neuroscience|September 1, 2022
Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted stateDominik Kriesche, Christian F J Woll, Nadja Tschentscher, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 9, 2007
Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffsStefan Leucht, John M Davis, Rolf R Engel, et al.The Journal of Clinical Psychiatry|May 3, 2006
Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project StudyGabriele Pitschel-Walz, Josef Bäuml, Wolfram Bender, et al.Pageof 7